Journal
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume 85, Issue 4, Pages 677-684Publisher
WILEY-BLACKWELL
DOI: 10.1002/ccd.25512
Keywords
transcatheter aortic valve replacement; TAVI; tricuspid regurgitation
Categories
Funding
- Swiss National Foundation
Ask authors/readers for more resources
ObjectivesSignificant tricuspid regurgitation (TR) is a marker for late-stage myocardial and valvular heart disease. Whether preoperative TR affects clinical outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) has never been investigated. This study sought to identify the impact of moderate and severe TR on outcomes after TAVR. MethodsAll patients undergoing TAVR from January 2007 to August 2012 at St. Paul's Hospital, Vancouver, Canada, (n=518) were dichotomized according to the severity of preoperative TR (moderate/severe vs. none/mild). All clinical outcomes were defined according to the valve academic research consortium-2 definitions. ResultsAt baseline, moderate or severe TR was reported in 79 patients (15.2%). At 30 days, moderate/severe TR had improved in 12 patients (15.2%), was unchanged in 46 patients (58.3%), and worsened in 7 patients (8.9%). Of those with none/mild TR at baseline, 35 (7.9%) patients had moderate TR at 30-day follow-up. Two-year all-cause (38.4% vs. 20.0%, Log-rank test, P=0.001) and cardiac mortality (12.9% vs. 4.6%, Log-rank test, P=0.004) as estimated by Kaplan-Meier analysis were considerably higher in patients with significant TR. However, significant TR did not emerge as independent risk factor for 2-year all-cause mortality (adjusted OR: 1.55, 95% confidence interval (CI): 0.91-2.64, P=0.105). Pre-specified subgroups showed an interaction between TR and left ventricular systolic function (P-interaction=0.047). Indeed, moderate/severe TR was significantly related to mortality only in patients with left ventricular ejection fraction (LVEF)>40% (adjusted OR: 2.01, CI: 1.05-3.84, P=0.036). In patients with LVEF40%, TR had no significant impact on all-cause mortality (adjusted OR: 1.04, CI: 0.34-3.16, P=0.946). No significant interactions were identified regarding patients with perioperative moderate/severe mitral regurgitation (P-interaction=0.829) and patients with baseline systolic pulmonary artery pressure60 mm Hg (P-interaction=0.669). ConclusionsIn patients undergoing TAVR, significant preoperative TR was present in 15% of patients and associated with more comorbidities. Despite being associated with a doubling of mortality rate, after a robust adjustment, significant TR was not an independent predictor of 2-year mortality. However, a significant interaction between TR and left ventricular systolic function was found. The response of TR to TAVR was extremely variable. (c) 2014 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available